title: [Portal anticoagulation in preventing thrombosis after porta-azygous devascularization for portal hypertension].
abstract: OBJECTIVE
  To study the prevention method for thrombosis after porta-azygous devascularization for portal hypertension.
  
  
  METHODS
  71 patients with portal hypertension due to cirrhosis were divided into group A (36 patients) and group B (35 patients). In group A, a anticoagulation tube was inserted via splenic vein branch during shunt and anticoagulation therapy was given after operation.
  
  
  RESULTS
  All the patients received color Doppler examination 3 months after operation. No thrombosis occurred in the group A and thrombosis occurred in 13 patients (37.14%) in the group B.
  
  
  CONCLUSIONS
  Portal anticoagulation therapy is the effective in preventing portal thrombosis after porta-azygous devascularization for portal hypertension.
authors.affiliation: Department of Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China.
authors.forename: H
authors.initials: H
authors.lastname: Xue
authors.forename: H
authors.initials: H
authors.lastname: Zhang
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.forename: Q
authors.initials: Q
authors.lastname: Jiang
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D006502:Budd-Chiari Syndrome / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000601:surgery*; D007262:Infusions, Intravenous; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D013164:Splenorenal Shunt, Surgical / Q000009:adverse effects / Q000379:methods
chemical_list: D000925:Anticoagulants